Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice

Journal of Immunology

Volumn 175, Issue 8, 2005, Pages 4897-4903

  Fukushima, Atsuki ^a   Yamaguchi, Tomoko ^a   Ishida, Waka ^a   Fukata, Kazuyo ^a   Mittler, Robert S ^b   Yagita, Hideo ^c   Ueno, Hisayuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD137 ANTIBODY; CD137 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGIC CONJUNCTIVITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; EOSINOPHIL; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH2 CELL;

EID: 26844577971     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.8.4897     Document Type: Article

References (36)

1. Leonardi, A. 1999. Pathophysiology of allergic conjunctivitis. Acta Ophthalmol. Scand. 228: 21-23.
2. Fukagawa, K., T. Nakajima, K. Tsubota, S. Shimmura, H. Saito, and K. Hirai. 1999. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J. Allergy Clin. Immunol. 1036: 1220-1121.
3. Trocme, S. D., C. K. Hallberg, K. S. Gill, G. J. Gleich, S. K. Tyring, and M. M. Brysk. 1997. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest. Ophthalmol Visual Sci. 38: 593-599.
4. Messmer, E. M., C. A. May, F. H. Stefani, U. Welge-Luessen, and A. Kampik. 2002. Toxic eosinophil granule protein deposition in corneal ulcerations and scars associated with atopic keratoconjunctivitis. Am. J. Ophthalmol. 134: 816-814.
5. Mochizuki, M., J. Schroder, E. Christophers, and S. Yamamoto. 1999. IL-4 induces eotaxin in human dermal fibroblasts. Int. Arch. Allergy Immunol. 120: 19-23.
6. Maher, D. W., I. Davis, A. W. Boyd, and G. Morstyn. 1991. Human interleukin-4: an immunomodulator with potential therapeutic applications. Prog. Growth Factor Res. 3: 43-56.
7. Fujishima, H., T. Takeuchi, N. Shinozaki, I. Saito, and K. Tsubota. 1995. Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin. Exp. Immunol. 102: 395-398.
8. Uchio, E., S. Y. Ono, Z. Ikezawa, and S. Ohno. 2000. Tear levels of interferon-γ, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin. Exp. Allergy 30: 103-109.
9. Yoshida, O., H. Yoshida, H. Iwamoto, K. Nishino, A. Fukushima, and H. Ueno. 1999. Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC). Curr. Eye Res. 18: 117-124.
10. Fukushima, A., A. Ozaki, K. Fukata, W. Ishida, and H. Ueno. 2003. Ag-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis. Invest. Ophthalmol. Visual Sci. 44: 4366-4374.
11. Fukushima, A., A. Ozaki, Z. Jian, W. Ishida, K. Fukata, H. Ueno, and F.-T. Liu. 2005. Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice. Curr. Eye Res. 30: 241-248.
12. Fukushima, A., T. Yamaguchi, A. Ozaki, T. Taniguchi, K. Udaka, and H. Ueno. Fyn regulates eosinophil infiltration into the conjunctiva by down-regulating the Th2 response. Graefes Arch. Clin. Exp. Ophthalmol. In press.
13. Fukushima, A., T. Yamaguchi, W. Ishida, K. Fukata, T. Taniguchi, F.-T. Liu, and H. Ueno. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of BALB/c and C57BL/6 mice. Exp. Eye Res. In press.
14. Pollok, K. E., Y. J. Kim, Z. Zhou, J. Hurtado, K. K. Kim, R. T. Pickard, and B. S. Kwon. 1993. Inducible T cell antigen 4-1BB: analysis of expression and function. J. Immunol. 150: 771-781.
15. Melero, I., W. W. Shuford, S. A. Newby, A. Aruffo, J. A. Ledbetter, K. E. Hellstrom, R. S. Mittler, and L. Chen. 1997. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3: 682-685.
16. Melero, I., J. V. Johnston, W. W. Shufford, R. S. Mittler, and L. Chen. 1998. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell. Immunol. 190: 167-172.
17. Wilcox, R. A., A. I. Chapoval, K. S. Gorski, M. Otsuji, T. Shin, D. B. Flies, K. Tamada, R. S. Mittler, H. Tsuchiya, D. M. Pardoll, and L. Chen. 2002. Expression of functional CD137 receptor by dendritic cells. J. Immunol. 168: 4262-427.
18. Futagawa, T., H. Akiba, T. Kodama, K. Takeda, Y. Hosoda, H. Yagita, and K. Okumura. 2002. Expression and function of 4-1BB and 4-1BB ligand on mutine dendritic cells. Int. Immunol. 14: 275-286.
19. Ye, Z., I. Hellstrom, M. Hayden-Ledbetter, A. Dublin, J. A. Ledbetter, and K. E. Hellstrom. 2002. Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nat. Med. 8: 343-348.
20. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186: 47-44.
21. Melero, I., N. Bach, K. E. Hellstrom, A. Arutto, R. S. Mittler, and L. Chen. 1998. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway. Eur. J. Immunol. 28: 1116-1121.
22. Mittler, R. S., T. S. Bailey, K. Klussman, M. D. Trailsmith, and M. K. Hoffmann. 1999. Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell energy. J. Exp. Med. 190: 1535-1540.
23. Sun, Y., H. M. Chen, S. K. Subudhi, J. Chen, R. Koka, L. Chen, and Y. X. Fu. 2002. Cosfimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat. Med. 8: 1405-1413.
24. 1 mice. J. Clin. Invest. 111: 1505-1518.
25. Foell, J. L., B. I. Diez-Mendiondo, O. H. Diez, U. Holzer, P. Ruck, A. S. Bapat, M. K. Hoffmann, R. S. Minler, and G. E. Dannecker. 2004. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance. Immunology 113: 89-98.
26. Seo, S. K., J. H. Choi, Y. H. Kim, W. J. Kang, H. Y. Park, J. H. Suh, B. K. Choi, D. S. Vinay, and B. S. Kwon. 2004. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat. Med. 10: 1088-1094.
27. Blazar, B. R., C. J. Lees, P. J. Martin, R. J. Noelle, B. Kwon, W. Murphy, and P. A. Taylor. 2000. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions. J. Immunol. 165: 4901-499.
28. Tan, J. T., J. K. Whitmire, K. Murali-Krishna, R. Ahmed, J. D. Altman, R. S. Mittler, A. Sette, T. C. Pearson, and C. P. Larsen. 2000. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J. Immunol. 164: 2320-235.
29. Magone, M. T., S. M. Whitcup, A. Fukushima, C. C. Chan, P. B. Silver, and L. V. Rizzo. 2000. The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitis. J. Allergy Clin. Immunol. 105: 299-308.
30. Fukushima, A., K. Fukata, A. Ozaki, M. Takata, N. Kuroda, H. Enzan, and H. Ueno. 2002. Exertion of the suppressive effects of IFN-γ on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase. Br. J. Ophthalmol. 86: 1166-1171.
31. + T cells modulate late allergic airway responses in Brown Norway rats. J. Immunol. 163: 5574-5581.
32. + T cells. Proc. Natl. Acad. Sci. USA 101; 6116-6121.
33. Miller, R. E., J. Jones, T. Le, J. Whitmore, N. Boiani, B. Gliniak, and D. H Lynch. 2002. 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner. J. Immunol. 169: 1792-174.
34. Lee, S. W., A. T. Vella, B. S. Kwon, and M. Croft. 2005. Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J. Immunol. 174: 6803-688.
35. + T cells. Blood 105: 2206-2213.
36. Myers, L., C. Takahashi, R. S. Mittler, R. J. Rossi, and A. T. Vella. 2003. Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering. Proc. Natl. Acad. Sci. USA 100: 5348-5353.